Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 14(1): 13098, 2024 06 11.
Article in English | MEDLINE | ID: mdl-38862573

ABSTRACT

Human space exploration poses inherent risks to astronauts' health, leading to molecular changes that can significantly impact their well-being. These alterations encompass genomic instability, mitochondrial dysfunction, increased inflammation, homeostatic dysregulation, and various epigenomic changes. Remarkably, these changes bear similarities to those observed during the aging process on Earth. However, our understanding of the connection between these molecular shifts and disease development in space remains limited. Frailty syndrome, a clinical syndrome associated with biological aging, has not been comprehensively investigated during spaceflight. To bridge this knowledge gap, we leveraged murine data obtained from NASA's GeneLab, along with astronaut data gathered from the JAXA and Inspiration4 missions. Our objective was to assess the presence of biological markers and pathways related to frailty, aging, and sarcopenia within the spaceflight context. Through our analysis, we identified notable changes in gene expression patterns that may be indicative of the development of a frailty-like condition during space missions. These findings suggest that the parallels between spaceflight and the aging process may extend to encompass frailty as well. Consequently, further investigations exploring the utility of a frailty index in monitoring astronaut health appear to be warranted.


Subject(s)
Aging , Biomarkers , Frailty , Space Flight , Aging/genetics , Animals , Mice , Humans , Astronauts , Male , Weightlessness/adverse effects , Sarcopenia/metabolism
2.
Nature ; 2024 Jun 11.
Article in English | MEDLINE | ID: mdl-38862027

ABSTRACT

The recent acceleration of commercial, private and multi-national spaceflight has created an unprecedented level of activity in low Earth orbit, concomitant with the largest-ever number of crewed missions entering space and preparations for exploration-class (lasting longer than one year) missions. Such rapid advancement into space from many new companies, countries and space-related entities has enabled a 'second space age'. This era is also poised to leverage, for the first time, modern tools and methods of molecular biology and precision medicine, thus enabling precision aerospace medicine for the crews. The applications of these biomedical technologies and algorithms are diverse, and encompass multi-omic, single-cell and spatial biology tools to investigate human and microbial responses to spaceflight. Additionally, they extend to the development of new imaging techniques, real-time cognitive assessments, physiological monitoring and personalized risk profiles tailored for astronauts. Furthermore, these technologies enable advancements in pharmacogenomics, as well as the identification of novel spaceflight biomarkers and the development of corresponding countermeasures. In this Perspective, we highlight some of the recent biomedical research from the National Aeronautics and Space Administration, Japan Aerospace Exploration Agency, European Space Agency and other space agencies, and detail the entrance of the commercial spaceflight sector (including SpaceX, Blue Origin, Axiom and Sierra Space) into aerospace medicine and space biology, the first aerospace medicine biobank, and various upcoming missions that will utilize these tools to ensure a permanent human presence beyond low Earth orbit, venturing out to other planets and moons.

3.
Macromol Rapid Commun ; 31(2): 183-9, 2010 Jan 18.
Article in English | MEDLINE | ID: mdl-21590890

ABSTRACT

The absorption and desorption of water, as well as the retention of certain molecules within a polymeric network, have special interest in a wide range of applications, including drug delivery, biosensing, chemical separation, catalysis, and optics. In this communication, we report the encapsulation by electrospinning of poly(N-isopropylacrylamide)-based monodisperse microgels within microfibers of crosslinked poly(vinylpyrrolidone), which is a hydrogel itself, up to concentrations of 40 wt.-% of the microgels. We present an optical characterization of these composite microfibers and quantify their absorbance, which can be as large as 17 times their de-swollen weight. Interestingly, this absorbance can be tuned by controlling the values of the temperature and the pH of the medium.

SELECTION OF CITATIONS
SEARCH DETAIL